4//SEC Filing
STEPHENSON BRIAN C 4
Accession 0000950170-24-129452
CIK 0001743881other
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 7:57 PM ET
Size
5.1 KB
Accession
0000950170-24-129452
Insider Transaction Report
Form 4
STEPHENSON BRIAN C
Secretary, Treasurer & CFO
Transactions
- Sale
Common Stock
2024-11-19$22.41/sh−4,156$93,137→ 93,758 total
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 22, 2024.
- [F2]Represents the weighted average sale price of the shares sold ranging from $21.95 to $22.78 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
Documents
Issuer
BridgeBio Pharma, Inc.
CIK 0001743881
Entity typeother
Related Parties
1- filerCIK 0001780030
Filing Metadata
- Form type
- 4
- Filed
- Nov 19, 7:00 PM ET
- Accepted
- Nov 20, 7:57 PM ET
- Size
- 5.1 KB